key: cord-0945830-tbldya78
authors: Liu, Chao; Zhu, Xiaoxiao; Lu, Yiyao; Zhang, Xianqin; Jia, Xu; Yang, Tai
title: Potential Treatment of Chinese and Western Medicine Targeting Nsp14 of SARS-CoV-2
date: 2020-09-07
journal: J Pharm Anal
DOI: 10.1016/j.jpha.2020.08.002
sha: aa4d7065c660f7b2d18caecbd8f462c6ce1ffa70
doc_id: 945830
cord_uid: tbldya78

The outbreak of coronavirus disease 2019 (COVID-19) by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is a serious global health threat. This raises an urgent need for the development of effective drugs against the deadly disease. SARS-CoV-2 nonstructural protein 14 (NSP14) carrying RNA cap guanine N7-methyltransferase and 3'-5' exoribonuclease activities could be a potential drug target for intervention. NSP14 of SARS-CoV-2 shared 98.7% similarity with the one (PDB 5NFY) of acute respiratory syndrome (SARS) by ClustalW. Then, the SARS-CoV-2 NSP14 structures were modelled by Modeller9.18 using SARS NSP14 (PDB 5NFY) as template for virtual screening. Based on the docking score from AutoDock Vina1.1.2, 18 small molecule drugs were selected for further evaluation. Based on the 5 ns MD simulation trajectory, binding free energy (ΔG) was calculated by MM/GBSA method. The calculated binding free energies of Saquinavir, Hypericin, Baicalein and Bromocriptine for the N-terminus of the homology model were -37.2711±3.2160, -30.1746±3.1914, -23.8953±4.4800, -34.1350±4.3683 kcal/mol, respectively, while the calculated binding free energies were -60.2757±4.7708, -30.9955±2.9975, -46.3099±3.5689, -59.8104±3.5389 respectively when binding to the C-terminus. Thus, the compounds including Saquinavir, Hypericin, Baicalein and Bromocriptine, could bind the N-terminus and C-terminus of the homology model of the SARS-CoV-2 Nsp14, providing as a candidate drug against SARS-CoV-2 for further study.

The emergence of SARS-CoV-2 has caused a large global outbreak and is a ma-37 jor public health issue. The high affinity of Spike protein for binding to human ACE2 38 protein makes SARS-CoV-2 spread rapidly in the population [1, 2] . Importantly, the The SARS-CoV-2 genome is a positive-sense, single-stranded mRNA, which 45 contains a 5′-cap structure and a 3′-poly (A) tail [4] . The large replicase polyprotein 46 1a (pp1a) and pp1b, which are encoded by the 5′-terminal open reading frame 1a/b (ORF1a/b) at the 5′-terminus of the CoV genome, which are cleaved by viral proteas-48 es to produce non-structural proteins (NSPs) such as RNA-dependent RNA polymer-49 ase (RdRp) and helicase (NSP13) [5] . In addition, the non-structural proteins 14 50 (NSP14) plays an important role in the virus' genome replication and transcription, 51 and it is generally conserved as an important functional protein in the coronavirus 52 family [6, 7] . NSP14 is a bifunctional enzyme carrying S-adenosyl methionine (SAM) 53 dependent (guanine-N7) N7-methyl transferase (N7-MTase) and 3′-5′ exoribonuclease cap modification, the cap structure at the 5′ end of viral mRNA assists in translation 56 and evading host defense [9] . The N-terminal 3′-5′ ExoN plays a proofreading role for 57 prevention of lethal mutagenesis [5, 8] , which provides an attractive target for drug 58 design. Computational protein-ligand docking and virtual drug screening could accel-59 erate the discovery of the potential drugs as potential candidates against COVID-19.

Compounds based on virtual screening, such as ribavirin, lopinavir and ritonavir, have 61 been shown to inhibit SARS-CoV-2 replication in vitro [10] [11] [12] [13] . In this work, the pro- two-metal-ion-assisted mechanism for removal of misincorporated nucleotides [14, 81 15], and the position of Mg 2+ is also considered to be the active center of exonuclease 82 J o u r n a l P r e -p r o o f [8] . Therefore, the docking box was set in a pocket formed by amino acid residues 83 (D90, V91, E191, G189, H188, A187, W186, T277 and D273) around Mg 2+ (Fig. 1A) . 84 The docking box of N7-MTase of NSP14 was set where the substrates GpppA and 85 SAM are located (Fig. 1B) [8] , and the key amino acids was organized in Table S1 . 86 The ligands were downloaded from the ZINC database (FDA, world-not-FDA, Each simulation system was immersed in a cubic box of TIP3P water with 10 Å 95 distance from the solute. The Na + or Clwas applied to neutralize the system. General C-terminus (Fig. 3C) . Hypericin can bind to the N-and C-terminal active pockets of 152 the SARS-CoV-2 Nsp14 as well (Fig. 2B, D) . Hypericin has been proven to have in-153 hibitory effects on human hepatitis C virus (HCV) and human immunodeficiency vi-154 rus (HIV) [20] . Combined the present study, Hypericin may have potential antiviral 155 effect against SARS-CoV-2. Shuanghuanglian oral liquid, composed of Hypericum 156 perforatum L, has been widely used for the treatment of viral influenza. However, J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

59.8104±3.5389 respectively when binding to the C-terminus

SARS-CoV-2 NSP 14 shares 98.7% sequence similarity with 202 the corresponding one in SARS (Fig. S1). Thus, the homology model of SARS-CoV-2 203 NSP14 was structured for virtual screening. Based on the docking score, 18 drugs 204 were selected for further evaluation

Bromocriptine) could bind to the N-terminal and C-terminal domains of SARS-CoV-2

Combined the anti-viral function of above four drugs reported by the pub-208 lished literatures, we suggest the anti-SARS-CoV-2 effects of above four drugs should 209 be evaluated in the cell culture models with SARS-CoV-2 infection

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

SARS-CoV-2, SARS-CoV, and 225 MERS-COV: A comparative overview

A Novel Coronavirus from Patients with Pneumonia in China

Structural and molecular basis of 230 mismatch correction and ribavirin excision from coronavirus RNA

The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing

The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing

Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex

Conventional and unconventional mechanisms for capping viral mRNA

Virtual screening, AD-245 COVID-19

Peptide-like and small-molecule inhibitors against Covid-19

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

Treatment options for COVID-19: The reality and challenges

Biochemical characterization of exoribonuclease encoded by SARS coronavirus

Structural basis for proofreading during replication of the Escherichia coli chromosome

Safety and activity of saquinavir in HIV 265 infection

Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation

The anti-HIV-1 effect of scutellarin

Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in 285 H5N1 influenza A virus-infected cells

Ethyl Acetate, and Chloroform Extracts of Scutellaria baicalensis Inhibit the Neuraminidase Activity of Pandemic 2009 H1N1 and Seasonal Influenza A Viruses

Inhibition of SARS Coronavirus Helicase by Baicalein

Novel antiviral activity of bromocriptine against 295 dengue virus replication

Novel antiviral activity and mechanism of bromocriptine as a Zika virus NS2B-NS3 protease inhibitor

The binding model of Saquinavir against SARS-CoV-2 NSP14. (A) Interactions between

Saquinavir (cyan) and associated residues (off-white) in the N-terminus of the homology model for SARS-CoV-2; (B) Binding models of Saquinavir (cyan) in the SARS-CoV-2 NSP14 protein N-terminus pocket

Interactions between Saquinavir (cyan) and associated residues (off-white) in the C-terminus of the homology model for SARS-CoV-2